Shares of Reckitt Benckiser Group plc (OTCMKTS:RBGLY - Get Free Report) have earned a consensus rating of "Buy" from the eight ratings firms that are covering the stock, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating, two have assigned a buy rating and three have given a strong buy rating to the company.
RBGLY has been the topic of a number of research analyst reports. Royal Bank of Canada restated an "outperform" rating on shares of Reckitt Benckiser Group in a research note on Friday, March 7th. Barclays lowered shares of Reckitt Benckiser Group from an "overweight" rating to an "equal weight" rating in a research report on Tuesday, February 4th.
Get Our Latest Report on RBGLY
Reckitt Benckiser Group Price Performance
OTCMKTS:RBGLY traded up $0.08 during trading hours on Friday, hitting $13.00. The company's stock had a trading volume of 350,638 shares, compared to its average volume of 355,463. Reckitt Benckiser Group has a twelve month low of $10.27 and a twelve month high of $14.10. The company has a debt-to-equity ratio of 0.97, a quick ratio of 0.47 and a current ratio of 0.69. The stock has a fifty day simple moving average of $13.26 and a 200-day simple moving average of $12.67.
Reckitt Benckiser Group Increases Dividend
The firm also recently announced a dividend, which will be paid on Thursday, June 5th. Shareholders of record on Friday, April 11th will be issued a dividend of $0.2909 per share. This is a positive change from Reckitt Benckiser Group's previous dividend of $0.19. The ex-dividend date is Friday, April 11th.
About Reckitt Benckiser Group
(
Get Free ReportReckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Articles
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
